医美耗材

Search documents
爱美客跌2.03%,成交额3.49亿元,主力资金净流出3153.09万元
Xin Lang Cai Jing· 2025-09-02 02:59
资金流向方面,主力资金净流出3153.09万元,特大单买入1781.42万元,占比5.10%,卖出2932.50万 元,占比8.39%;大单买入7995.57万元,占比22.88%,卖出9997.58万元,占比28.61%。 爱美客今年以来股价涨7.94%,近5个交易日跌2.43%,近20日涨4.87%,近60日涨12.09%。 资料显示,爱美客技术发展股份有限公司位于北京市朝阳区建国路甲92号世茂大厦C座21层,成立日期 2004年6月9日,上市日期2020年9月28日,公司主营业务涉及从事生物医用软组织修复材料的研发、生 产和销售。主营业务收入构成为:溶液类注射产品57.27%,凝胶类注射产品37.97%,其他3.01%,冻干 粉类注射产品1.50%,面部埋植线0.26%。 爱美客所属申万行业为:美容护理-医疗美容-医美耗材。所属概念板块包括:化妆品、MSCI中国、大 盘、百元股、高派息等。 截至8月29日,爱美客股东户数5.51万,较上期减少0.89%;人均流通股3787股,较上期增加0.90%。 2025年1月-6月,爱美客实现营业收入12.99亿元,同比减少21.59%;归母净利润7.89亿元,同比 ...
华熙生物涨2.03%,成交额2.46亿元,主力资金净流出71.07万元
Xin Lang Cai Jing· 2025-09-01 05:21
9月1日,华熙生物盘中上涨2.03%,截至13:02,报58.36元/股,成交2.46亿元,换手率0.89%,总市值 281.11亿元。 资金流向方面,主力资金净流出71.07万元,特大单买入682.08万元,占比2.77%,卖出1277.61万元,占 比5.19%;大单买入5611.04万元,占比22.80%,卖出5086.59万元,占比20.66%。 分红方面,华熙生物A股上市后累计派现11.38亿元。近三年,累计派现5.28亿元。 机构持仓方面,截止2025年6月30日,华熙生物十大流通股东中,华夏上证科创板50成份ETF (588000)位居第三大流通股东,持股1064.29万股,相比上期减少24.48万股。易方达上证科创板 50ETF(588080)位居第四大流通股东,持股797.77万股,相比上期增加22.78万股。华宝中证医疗ETF (512170)位居第五大流通股东,持股643.29万股,为新进股东。香港中央结算有限公司位居第七大流 通股东,持股579.90万股,相比上期增加131.24万股。招商国证生物医药指数A(161726)位居第九大 流通股东,持股293.38万股,相比上期减少21.9 ...
华熙生物涨2.10%,成交额2.98亿元,主力资金净流出1477.66万元
Xin Lang Cai Jing· 2025-08-27 06:22
责任编辑:小浪快报 8月27日,华熙生物盘中上涨2.10%,截至13:06,报59.40元/股,成交2.98亿元,换手率1.06%,总市值 286.12亿元。 资金流向方面,主力资金净流出1477.66万元,特大单买入448.58万元,占比1.50%,卖出1371.44万元, 占比4.59%;大单买入6117.73万元,占比20.50%,卖出6672.52万元,占比22.35%。 华熙生物今年以来股价涨16.63%,近5个交易日涨7.67%,近20日涨12.29%,近60日涨6.87%。 资料显示,华熙生物科技股份有限公司位于山东省济南市高新技术开发区天辰大街678号,成立日期 2000年1月3日,上市日期2019年11月6日,公司主营业务涉及微生物发酵和交联两大技术平台,开发有助 于人类生命健康的生物活性材料,建立了从原料到医疗终端产品、功能性护肤品及功能性食品的全产业 链业务体系,服务于全球的医药、化妆品、食品制造企业、医疗机构及终端用户。主营业务收入构成 为:皮肤科学创新转化业务47.84%,医疗终端产品26.80%,原料产品23.02%,其他2.17%,其他(补 充)0.18%。 华熙生物所属申万行业 ...
爱美客跌2.02%,成交额7.78亿元,主力资金净流出7435.37万元
Xin Lang Cai Jing· 2025-08-27 05:54
8月27日,爱美客盘中下跌2.02%,截至13:46,报193.70元/股,成交7.78亿元,换手率1.91%,总市值 586.12亿元。 资金流向方面,主力资金净流出7435.37万元,特大单买入5645.80万元,占比7.26%,卖出9929.00万 元,占比12.76%;大单买入1.89亿元,占比24.29%,卖出2.20亿元,占比28.34%。 爱美客今年以来股价涨8.38%,近5个交易日涨2.76%,近20日涨2.19%,近60日涨7.76%。 资料显示,爱美客技术发展股份有限公司位于北京市朝阳区建国路甲92号世茂大厦C座21层,成立日期 2004年6月9日,上市日期2020年9月28日,公司主营业务涉及从事生物医用软组织修复材料的研发、生 产和销售。主营业务收入构成为:溶液类注射产品57.27%,凝胶类注射产品37.97%,其他3.01%,冻干 粉类注射产品1.50%,面部埋植线0.26%。 爱美客所属申万行业为:美容护理-医疗美容-医美耗材。所属概念板块包括:合成生物、MSCI中国、 化妆品、大盘、高派息等。 截至8月20日,爱美客股东户数5.56万,较上期减少0.09%;人均流通股3753股, ...
8月8日早间重要公告一览
Xi Niu Cai Jing· 2025-08-08 03:53
Group 1: 惠泉啤酒 - Company achieved a net profit of 39.57 million yuan in the first half of 2025, representing a year-on-year increase of 25.52% [1] - Revenue for the same period was 351 million yuan, showing a growth of 1.03% year-on-year [1] - Company specializes in the production and sale of beer, established in February 1997 [1] Group 2: 格尔软件 - Company plans to raise no more than 283 million yuan through a simplified procedure for issuing A-shares [1] - The funds will be used for quantum password technology industrialization, trusted data space platform development, and to supplement working capital [1] - Established in March 1998, the company focuses on digital trust and data security products [1] Group 3: 银轮股份 - Certain directors and executives plan to reduce their holdings by up to 964,000 shares, accounting for 0.1158% of the total share capital [1] - The reduction is due to personal funding needs [1] - Company specializes in heat exchange products and automotive air conditioning, established in March 1999 [2] Group 4: 共创草坪 - Controlling shareholder's related parties plan to reduce their holdings by up to 0.8% of the company's shares [3] - The reduction will occur through centralized bidding and block trading [3] - Company focuses on the research, production, and sale of artificial turf, established in January 2004 [3] Group 5: ST纳川 - Senior management plans to reduce their holdings by up to 27,200 shares, representing 0.0026% of the total share capital [4] - The reduction is due to personal funding needs [4] - Company specializes in the research, manufacturing, and sales of water supply and drainage pipes, established in June 2003 [4] Group 6: 东芯股份 - Company clarified that its investment in Shanghai Lisan's chip products is not intended for large model computing clusters [6] - The products are mainly for personal computers, professional design, cloud gaming, and other applications [6] - Established in November 2014, the company focuses on independent research, design, and sales of small-capacity storage chips [6] Group 7: 南卫股份 - Company and its controlling shareholder received an administrative penalty notice from Jiangsu Securities Regulatory Bureau for insider trading [6] - The financial director and the controlling shareholder face fines and confiscation of illegal gains [6] - Established in July 1990, the company specializes in medical adhesive products and protective supplies [7] Group 8: 兰花科创 - Company plans to acquire 62% of Shandong Jiaxiang Yilong Port Co., Ltd. for 149 million yuan [8] - This acquisition aims to enhance the company's presence in inland shipping and logistics [8] - Established in December 1998, the company focuses on the production and sale of coal, fertilizers, and building materials [9] Group 9: 伟隆股份 - Controlling shareholder's related party plans to reduce holdings by up to 1.89 million shares, accounting for 0.7664% of the total share capital [10] - The reduction will occur through centralized bidding or block trading [10] - Established in June 1995, the company specializes in the production and sales of valves and related components [10] Group 10: 埃夫特 - Company's subsidiary received a government subsidy of 50 million yuan for a project related to intelligent robots [11] - The subsidy is pending receipt [11] - Established in August 2007, the company focuses on the research, production, and sales of industrial robots [11] Group 11: 华测导航 - Company reported a net profit of 32.6 million yuan in the first half of 2025, a year-on-year increase of 29.94% [13] - Revenue for the same period was 1.833 billion yuan, reflecting a growth of 23.54% year-on-year [13] - Established in September 2003, the company specializes in high-precision navigation and positioning technologies [13] Group 12: 德生科技 - Company directors plan to reduce their holdings by up to 0.025% of the total share capital [14] - The reduction is due to personal funding needs [14] - Established in August 1999, the company focuses on the production and sales of social security cards and related services [15] Group 13: 百邦科技 - Company director plans to reduce holdings by up to 0.19% of the total share capital [16] - The reduction is due to personal funding needs [16] - Established in November 2007, the company specializes in mobile phone after-sales services [17] Group 14: 中集车辆 - Shareholders plan to reduce holdings by up to 0.69% of the total share capital [18] - The reduction will occur through centralized bidding and block trading [18] - Established in August 1996, the company focuses on the production and sales of semi-trailers and specialized vehicles [18] Group 15: 新时达 - Company’s application for a private placement was accepted by the Shenzhen Stock Exchange [19] - The application is subject to further review and approval by the regulatory authorities [19] - Established in March 1995, the company specializes in intelligent manufacturing and industrial robotics [19] Group 16: 隆扬电子 - Company plans to reduce up to 592,400 repurchased shares, accounting for 0.21% of the total share capital [20] - The reduction will occur through centralized bidding [20] - Established in March 2000, the company focuses on the research, production, and sales of electromagnetic shielding materials [20] Group 17: 华熙生物 - Controlling shareholder plans to increase holdings by 200 to 300 million yuan [21] - The increase will occur within six months at a price not exceeding 70 yuan per share [21] - Established in January 2000, the company specializes in the research, production, and sales of hyaluronic acid and related medical materials [21] Group 18: 天域生物 - Company reported sales revenue of 21.03 million yuan from pig sales in July, a year-on-year decrease of 37.23% [22] - Cumulative sales from January to July reached 333 million yuan, a year-on-year increase of 11.35% [22] - Established in June 2000, the company focuses on ecological agriculture and livestock farming [22] Group 19: 城地香江 - Subsidiary signed a significant data center hosting contract with an internet company, with an estimated first phase contract value of up to 1.811 billion yuan [23] - The second phase is expected to be valued at up to 2.716 billion yuan, with details yet to be specified [23] - Established in April 1997, the company specializes in IDC investment and operations [23]
中新健康丨江苏吴中突失“印钞机”?童颜针市场或将大洗牌
Zhong Guo Xin Wen Wang· 2025-07-25 08:09
Core Viewpoint - The market for "童颜针" (youthful face injection) is experiencing significant turmoil, with recent developments including the termination of exclusive distribution rights for Jiangsu Wuzhong and an increase in competition as more products gain approval for sale in China [1][4]. Company Summary - Jiangsu Wuzhong's subsidiary, Dato Medical, received a termination notice from Regen Biotech Inc., ending its exclusive distribution rights for AestheFill, the first imported "童颜针" in China [1][2]. - The termination is attributed to alleged violations of the distribution agreement and securities law by Jiangsu Wuzhong and its executives, which Regen claims have harmed the product's reputation [1][4]. - AestheFill is a critical product for Jiangsu Wuzhong, contributing significantly to its revenue, with projected sales of 326 million yuan in 2024, accounting for 20.42% of total revenue [3]. Industry Summary - The number of approved "童颜针" products in China has increased to nine, intensifying competition in the market [1][4]. - The high pricing of "童颜针" has historically positioned it as a lucrative product, but recent price reductions by competitors are threatening this status [5][7]. - The introduction of lower-priced alternatives, such as a 5,999 yuan version of Aivilan, has sparked controversy and dissatisfaction among established brands [7]. - Analysts predict that profit margins for "童颜针" may decline from 90% to below 80% as the industry approaches a price war [8]. - Concerns regarding product safety are rising, with reports of complications from excessive injections, prompting a need for differentiation, education, and compliance among companies [8].
7月22日早间重要公告一览
Xi Niu Cai Jing· 2025-07-22 05:03
Group 1 - Ruihu Mould achieved a net profit of 227 million yuan in the first half of 2025, a year-on-year increase of 40.33% [1] - The company reported an operating income of 1.662 billion yuan, representing a year-on-year growth of 48.3% [1] - The main business focuses on automotive manufacturing equipment and lightweight automotive components [1] Group 2 - Dongfang Fortune announced that shareholder Shen Yougen's inquiry transfer price is set at 21.66 yuan per share [1] - The transfer will not occur through centralized bidding or block trading, and the shares cannot be transferred within six months [1] - The company specializes in securities, financial e-commerce services, and financial data services [1] Group 3 - Yunnan Copper plans to purchase 40% of Liangshan Mining for 2.324 billion yuan through a share issuance [3] - The transaction involves issuing shares to the controlling shareholder and indirect controlling shareholder to raise matching funds [3] - The company is engaged in copper exploration, mining, smelting, and processing of precious and rare metals [3] Group 4 - Changchuan Technology reported a net profit of 427 million yuan in the first half of 2025, a year-on-year increase of 98.73% [15] - The company achieved an operating income of 2.167 billion yuan, reflecting a year-on-year growth of 41.8% [15] - The main business is focused on the research, production, and sales of integrated circuit equipment [15] Group 5 - ST Lingda reported a net loss of 105 million yuan in the first half of 2025, an improvement from a net loss of 168 million yuan in the same period last year [17] - The company achieved an operating income of 59.93 million yuan, a year-on-year increase of 72.39% [17] - The main business involves high-efficiency photovoltaic solar cells and photovoltaic power generation [17] Group 6 - Anning Co. plans to acquire 100% equity of three companies for 6.508 billion yuan through phased cash payments [14] - The acquisition aims to enhance resource reserves, business scale, market share, and profitability [14] - The company primarily engages in the mining, washing, and sales of vanadium-titanium magnetite [14] Group 7 - Huylv Ecological is planning a major asset restructuring, with stock suspension effective from July 22, 2025 [13] - The restructuring involves issuing shares and cash to acquire 49% equity of Wuhan Junheng Technology [13] - The company specializes in landscape engineering construction and design [13] Group 8 - ST Xifa is planning to acquire the remaining 50% equity of Lhasa Beer for cash, which will lead to full control of the company [26] - The transaction is in the planning stage and is expected to constitute a major asset restructuring [26] - The company is involved in the production and sales of beer [26]